KRINTAFEL

Peak

tafenoquine succinate

NDAORALTABLETPriority Review

Approved

Jul 2018

Lifecycle

Peak

Competitive Pressure

30/100

Mechanism of Action

8-aminoquinoline antimalarial drug [see Microbiology ()].

Indications (1)

Company

LONDON, United Kingdom

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers